Skip to main content

Table 1 DAVID Functional Annotation Charts, 2-h and 18-h Mild PE verses Vehicle

From: Differential effect of mild and severe pulmonary embolism on the rat lung transcriptome

Category

Term

a2-h Mild-PE vs. Vehicle

18-h Mild-PE vs. Vehicle

Ct

%

Dir

Fold

B&H

Ct

%

Dir

Fold

B&H

SP_PIR

acetylation

     

78

14.03

UP

1.51

0.009

rno04920

Adipocytokine signaling pathway

6

2.93

UP

7.47

0.015

     

rno00970

Aminoacyl-tRNA biosynthesis

     

8

1.44

UP

5.56

0.017

rno04210

Apoptosis

6

2.93

UP

5.89

0.028

     

rno00330

Arginine and proline metabolism

     

9

1.62

UP

4.72

0.015

rno05217

Basal cell carcinoma

     

10

1.11

D

4.28

0.016

IPR004827

Basic-leucine zipper (bZIP) transcription factor

7

3.41

UP

11.97

0.003

     

SM00338

BRLZ

7

3.41

UP

10.46

0.001

     

rno04062

Chemokine signaling pathway

12

5.85

UP

5.85

0.000

20

3.60

UP

3.25

0.001

SP_PIR

chemotaxis

9

4.39

UP

22.67

0.000

11

1.98

UP

10.30

0.000

rno04610

Complement and coagulation cascades

     

10

1.80

UP

3.97

0.019

SP_PIR

cytokine

11

5.37

UP

9.02

0.000

16

2.88

UP

4.88

0.000

rno04060

Cytokine-cytokine receptor interaction

10

4.88

UP

4.24

0.008

23

4.14

UP

3.25

0.000

rno04623

Cytosolic DNA-sensing pathway

5

2.44

UP

9.07

0.024

     

SP_PIR

disulfide bond

     

76

13.67

UP

1.43

0.044

SP_PIR

dna-binding

20

9.76

UP

2.43

0.023

     

rno00982

Drug metabolism

     

13

1.45

D

3.94

0.004

rno04512

ECM-receptor interaction

     

14

1.56

D

3.77

0.005

PIRSF001719

fos transforming protein

4

1.95

UP

59.84

0.001

     

IPR000837

Fos transforming protein

4

1.95

UP

40.08

0.010

     

rno00480

Glutathione metabolism

     

9

1.00

D

3.93

0.042

rno04640

Hematopoietic cell lineage

6

2.93

UP

6.42

0.022

     

rno00340

Histidine metabolism

     

7

0.78

D

6.37

0.017

SP_PIR

inflammatory response

8

3.90

UP

16.01

0.000

11

1.98

UP

8.18

0.000

rno04010

MAPK signaling pathway

10

4.88

UP

3.14

0.029

     

rno00980

Metabolism of xenobiotics by cytochrome P450

     

13

1.45

D

4.73

0.002

rno04621

NOD-like receptor signaling pathway

9

4.39

UP

12.11

0.000

10

1.80

UP

4.49

0.016

SP_PIR

oxidoreductase

     

42

4.68

D

1.89

0.034

rno05020

Prion diseases

     

7

1.26

UP

5.56

0.028

SP_PIR

ribosome biogenesis

     

7

1.26

UP

8.85

0.007

SM00199

SCY

8

3.90

UP

16.89

0.000

10

1.80

UP

8.76

0.000

IPR000827

Small chemokine, C-C group, conserved site

4

1.95

UP

25.50

0.033

     

IPR001811

Small chemokine, interleukin-8-like

8

3.90

UP

19.35

0.000

10

1.80

UP

8.70

0.001

PIRSF001950

small inducible chemokine, C/CC types

5

2.44

UP

24.93

0.001

     

rno04620

Toll-like receptor signaling pathway

9

4.39

UP

8.34

0.000

     
  1. Functional annotations significantly over-represented in the lists of up-regulated and down-regulated genes during 2-h and 18-h Low-PE. Annotations unique to Low-PE are highlighted in bold italics; annotations common to Low-PE and High-PE (Table 2) are in standard font. Key: “Ct.”, number genes from a GeneSifter pairwise t-test result (Additional file 3A-C) that were present in the functional annotation indicated; “%”, percent of genes contained within a list that were present in an annotation; “Dir, UP”, annotations that were identified by DAVID when up-regulated genes were used as the search query; “Dir, D”, annotations that were identified by DAVID when down-regulated genes were used as the search query. “Fold”, expression relative to vehicle group; B&H, value of Benjamini and Hochberg adjustment for false discovery following t-test. aNo 2-h DOWN annotations meet B&H < 0.05